Skip to main content

Advertisement

Log in

Analysis of the Efficiency of Different Antituberculous Drugs and Approaches to Treat BCG-Induced Granulomatosis in Mice and Abundance and Localization of Mycobacterium tuberculosis in the Liver

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

In 3 months after infection with Mycobacterium tuberculosis (MBT) from BCG vaccine, male BALB/с mice received intraperitoneal injections of isonicotinic acid hydrazide, dextrazide, or liposome-encapsulated dextrazide, or inhalation of liposome-encapsulated dextrazide 2 times a week for 6 months. In 6 months, no MBT were detected in macrophages outside granulomas in treated mice. Macrophages containing MBT can incorporate into granulomas and leave them after suppression of MBT persistence. Liposome-encapsulated dextrazide showed the maximum therapeutic efficiency: the total MBT level in granuloma macrophages and volume density of destruction foci in the liver parenchyma decreased by 5.1 and 5.3 times, respectively, in comparison with the corresponding parameters in mice treated with isonicotinic acid hydrazide. Inhalations of liposome-encapsulated dextrazide prevented the destructive processes in liver granulomas due to macrophage migration from granulomas, which reduced granuloma sizes and destructive potential of granuloma lysosomes and therefore improved their diffusion-dependent trophics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arkhipov SA, Shkurupy VA, Neshchadim DV, Akhramenko ES, Troitsky AV, Iljin DA, Gulyaeva EP. Study of biocompatibility liposomes with antituberculous drug (dextrazide) in the macrophage cultures. Mezhdunarod. Zh. Priklad. Fundament. Issled. 2015;(9-1):74-78. Russian.

  2. Shkurupij VA, Kopylov AN, Troitskij AV. Patent RU No. 2618341. Method for oxidized dextran obtaining. Bull. No. 13. Published May 3, 2017.

  3. Shkurupij VA, Troitskij AV, Luzgina NG, Potapova OV. Patent RU No. 2372914. Pharmaceutical tuberculosis composition. Bull. No. 32. Published November 20, 2009.

  4. Shkurupy VA. Tuberculosis Granulematosis. Cytophysiology and Target Therapy. Moscow, 2007. Russian.

  5. Shkurupiy VA, Arkhipov SA, Troitsky AV, Luzgina NG, Zaikovskaja MV, Gulyaeva EP, Bistrova TN, Ufimceva EG, Iljin DA, Akhramenko ES. Comparative study of the in vitro effect of nanoliposomes with oxidized dextrans on peritoneal cells. Bull. Exp. Biol. Med. 2008;146(6):871-874.

    Article  CAS  Google Scholar 

  6. Martin CJ, Carey AF, Fortune SM. A bug’s life in the granuloma. Semin. Immunopathol. 2016;38(2):213-220.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. M. Sinyavskaya.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 170, No. 8, pp. 205-208, August, 2020

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sinyavskaya, A.M., Shkurupy, V.A., Troitskii, A.V. et al. Analysis of the Efficiency of Different Antituberculous Drugs and Approaches to Treat BCG-Induced Granulomatosis in Mice and Abundance and Localization of Mycobacterium tuberculosis in the Liver. Bull Exp Biol Med 170, 233–235 (2020). https://doi.org/10.1007/s10517-020-05041-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-05041-y

Key Words

Navigation